Sternberg CN, Petrylak DP, Bellmunt J, Nishiyama H, et al. FORT-1: Phase II/III Study of Rogaratinib Versus Chemotherapy in Patients With Locally Advanced or Metastatic Urothelial Carcinoma Selected Based on FGFR1/3 mRNA Expression. J Clin Oncol 2023;41:629-639.
PMID: 36240478